FRI0428 the JAK1-selective Inhibitor, Filgotinib, Inhibits Inflammation Pathways Observed in an IL23-induced Psoriatic Arthritis Mouse Model

doi 10.1136/annrheumdis-2017-eular.4911
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Upadacitinib and Filgotinib: The Role of JAK1 Selective Inhibition in the Treatment of Rheumatoid Arthritis

Drugs in Context
Molecular MedicinePharmacology
2019English

Upadacitinib and Filgotinib: The Role of JAK1 Selective Inhibition in the Treatment of Rheumatoid Arthritis

Drugs in Context
Molecular MedicinePharmacology
2019English

Oxaceprol, an Atypical Inhibitor of Inflammation, Reduces Leukocyte Adherence in Mouse Antigen-Induced Arthritis

Acta Orthopaedica Scandinavica
2001English

Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results From Two Randomized, Controlled Phase 2b Trials

Rheumatology and Therapy
2020English

Eye Inflammation in Psoriatic Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1976English

015 the Adaptor Protein Act1 Plays a Key Role in Psoriatic Inflammation Mediated by IL23

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Mouse Ear Erosions: Psoriatic Arthritis

Journal of Medical Imaging and Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2018English

TNF Inhibitors and Periodontal Inflammation in Psoriatic Arthritis

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2017English

Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy